Hershko C - Search Results

1

High nontransferrin bound iron levels and heart disease in thalassemia major.

Piga A, Longo F, Duca L, Roggero S, Vinciguerra T, Calabrese R, Hershko C, Cappellini MD. Piga A, et al. Among authors: hershko c. Am J Hematol. 2009 Jan;84(1):29-33. doi: 10.1002/ajh.21317. Am J Hematol. 2009. PMID: 19006228 Free article.

2

Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.

Taher A, Hershko C, Cappellini MD. Taher A, et al. Among authors: hershko c. Br J Haematol. 2009 Dec;147(5):634-40. doi: 10.1111/j.1365-2141.2009.07848.x. Epub 2009 Aug 13. Br J Haematol. 2009. PMID: 19681884 Free article. Review.

3

Purging iron from the heart.

Hershko C, Cappellini MD, Galanello R, Piga A, Tognoni G, Masera G. Hershko C, et al. Br J Haematol. 2004 Jun;125(5):545-51. doi: 10.1111/j.1365-2141.2004.04946.x. Br J Haematol. 2004. PMID: 15147368 Free article. Review.

4

Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation.

Cabantchik IZ, Hershko C. Cabantchik IZ, et al. Among authors: hershko c. Am J Hematol. 2022 Jan 1;97(1):7-9. doi: 10.1002/ajh.26374. Epub 2021 Oct 19. Am J Hematol. 2022. PMID: 34637551 Free article. No abstract available.

5

Iron loading and its clinical implications.

Hershko C. Hershko C. Am J Hematol. 2007 Dec;82(12 Suppl):1147-8. doi: 10.1002/ajh.21070. Am J Hematol. 2007. PMID: 17963253 Free article.

6

The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation.

Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI. Breuer W, et al. Among authors: hershko c. Blood. 2000 May 1;95(9):2975-82. Blood. 2000. PMID: 10779448 Free article.

7

Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B(12) treatment.

Gafter-Gvili A, Prokocimer M, Breuer W, Cabantchik IZ, Hershko C. Gafter-Gvili A, et al. Among authors: hershko c. Hematol J. 2004;5(1):32-4. doi: 10.1038/sj.thj.6200332. Hematol J. 2004. PMID: 14745427

8

Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI. Esposito BP, et al. Among authors: hershko c. Blood. 2003 Oct 1;102(7):2670-7. doi: 10.1182/blood-2003-03-0807. Epub 2003 Jun 12. Blood. 2003. PMID: 12805056 Free article.

9

Pathogenesis and management of iron toxicity in thalassemia.

Hershko C. Hershko C. Ann N Y Acad Sci. 2010 Aug;1202:1-9. doi: 10.1111/j.1749-6632.2010.05544.x. Ann N Y Acad Sci. 2010. PMID: 20712765

10

The importance of non-transferrin bound iron in disorders of iron metabolism.

Breuer W, Hershko C, Cabantchik ZI. Breuer W, et al. Among authors: hershko c. Transfus Sci. 2000 Dec;23(3):185-92. doi: 10.1016/s0955-3886(00)00087-4. Transfus Sci. 2000. PMID: 11099894 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters